| |
| |
|
| Insider
Information: |
Casdin Eli |
| Relationship: |
Director |
| City: |
Madison |
| State: |
WI |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
18,894,431 |
|
|
Indirect Shares
|
147,334,950 |
|
|
| Direct
Value |
$239,924,947 |
|
|
|
Indirect Value
|
$2,603,202,664 |
|
|
| Total
Shares |
166,229,381 |
|
|
| Total
Value |
$2,843,127,611 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
20
|
2
|
|
Stock
price went up :
|
10
|
0
|
| Stock
price went down : |
10
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
 25.4%
|
 -48.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Exact Sciences Corp |
EXAS |
Director |
2020-07-23 |
8,820 |
2020-07-23 |
450 |
Premium* |
|
|
Fulcrum Therapeutics, Inc. |
FULC |
10% Owner |
2019-07-22 |
0 |
2019-07-22 |
604,285 |
Premium* |
|
|
Biolife Solutions Inc |
BLFS |
10% Owner |
2024-04-30 |
8,707,165 |
2024-04-30 |
0 |
Premium* |
|
|
Generation Bio Co. |
GBIO |
10% Owner |
2020-06-16 |
0 |
2020-06-16 |
1,611,215 |
Premium* |
|
|
Century Therapeutics, Inc. |
IPSC |
Director |
2021-06-22 |
0 |
2021-06-22 |
3,206,380 |
Premium* |
|
|
GeneDx Holdings Corp |
WGS |
Director |
2023-05-02 |
58,290 |
2023-05-02 |
113,145,535 |
Premium* |
|
|
Absci Corp |
ABSI |
Director |
2021-07-26 |
0 |
2021-07-26 |
973,260 |
Premium* |
|
|
Maxcyte, Inc. |
MXCT |
10% Owner |
2022-10-03 |
10,000,000 |
2021-07-30 |
0 |
Premium* |
|
|
Tenaya Therapeutics, Inc. |
TNYA |
Director, 10% Owner |
2021-08-03 |
0 |
2021-08-03 |
361,969 |
Premium* |
|
|
Cm Life Sciences Ii Inc. |
SLGC |
Director, 10% Owner |
2024-01-05 |
0 |
2024-01-05 |
0 |
Premium* |
|
|
EQRx, Inc. |
EQRX |
10% Owner |
2021-12-17 |
0 |
2023-11-09 |
0 |
Premium* |
|
|
Fluidigm Corp |
FLDM |
Director, 10% Owner |
2024-03-18 |
103,556 |
2024-03-18 |
25,431,856 |
Premium* |
|
|
2seventy Bio, Inc. |
TSVT |
Director |
2024-03-26 |
16,600 |
2024-03-26 |
2,000,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
68 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SLGC |
Cm Life Sciences Ii Inc. |
Director |
– • – |
2021-09-01 |
4 |
A |
$0.00 |
$0 |
I/I |
6,800,000 |
6,800,000 |
0 |
- |
|
| BLFS |
Biolife Solutions Inc |
10% Owner |
– – • |
2021-09-01 |
4/A |
A |
$0.00 |
$0 |
D/D |
131,428 |
7,571,535 |
0 |
- |
|
| EQRX |
EQRx, Inc. |
Director |
– • – |
2021-12-17 |
4 |
A |
$0.00 |
$0 |
I/I |
8,659,372 |
8,659,372 |
0 |
- |
|
| EQRX |
EQRx, Inc. |
Director |
– • – |
2021-12-17 |
4 |
A |
$0.00 |
$50,000,000 |
I/I |
39,527,671 |
48,187,043 |
0 |
- |
|
| EQRX |
EQRx, Inc. |
Director |
– • • |
2021-12-17 |
4/A |
OE |
$0.00 |
$0 |
I/I |
8,659,372 |
8,659,372 |
0 |
- |
|
| EQRX |
EQRx, Inc. |
Director |
– • • |
2021-12-17 |
4/A |
D |
$0.00 |
$0 |
I/I |
(8,659,372) |
0 |
0 |
- |
|
| EQRX |
EQRx, Inc. |
Director |
– • • |
2021-12-17 |
4/A |
A |
$0.00 |
$50,000,000 |
I/I |
39,527,670 |
5,488,164 |
0 |
- |
|
| SLGC |
Cm Life Sciences Ii Inc. |
Director |
– • – |
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,430 |
3,430 |
0 |
- |
|
| FLDM |
Fluidigm Corp |
Director |
– • • |
2022-04-04 |
4 |
A |
$0.00 |
$0 |
D/D |
15,852 |
15,852 |
0 |
- |
|
| WGS |
GeneDx Holdings Corp |
Director |
– • – |
2022-04-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,836 |
12,836 |
0 |
- |
|
| WGS |
GeneDx Holdings Corp |
Director |
– • – |
2022-04-29 |
4 |
B |
$4.00 |
$45,750,000 |
I/I |
11,437,500 |
16,437,500 |
2.1 |
% |
|
| FLDM |
Fluidigm Corp |
Director |
– • – |
2022-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
30,914 |
46,766 |
0 |
- |
|
| MXCT |
Maxcyte, Inc. |
10% Owner |
– – • |
2022-07-01 |
4 |
S |
$4.30 |
$13,912,856 |
D/D |
(3,235,548) |
10,735,786 |
0 |
% |
|
| SLGC |
Cm Life Sciences Ii Inc. |
Director |
– • – |
2022-09-29 |
4 |
A |
$0.00 |
$0 |
I/I |
215,193 |
10,132,005 |
0 |
- |
|
| MXCT |
Maxcyte, Inc. |
10% Owner |
– – • |
2022-10-03 |
4 |
S |
$6.15 |
$4,525,084 |
D/D |
(735,786) |
10,000,000 |
0 |
% |
|
| WGS |
GeneDx Holdings Corp |
Director |
– • • |
2023-01-31 |
4 |
B |
$0.35 |
$30,000,000 |
I/I |
85,714,285 |
14,285,743 |
2.25 |
% |
|
| SLGC |
Cm Life Sciences Ii Inc. |
Director |
– • – |
2023-03-17 |
4 |
A |
$0.00 |
$0 |
D/D |
3,430 |
6,860 |
0 |
- |
|
| WGS |
GeneDx Holdings Corp |
Director |
– • – |
2023-05-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
45,454 |
58,290 |
0 |
- |
|
| BLFS |
Biolife Solutions Inc |
10% Owner |
– – • |
2023-05-16 |
4 |
B |
$20.19 |
$302,835 |
I/I |
15,000 |
15,000 |
1.5 |
% |
|
| FLDM |
Fluidigm Corp |
Director |
– • • |
2023-05-17 |
4 |
B |
$1.89 |
$471,550 |
I/I |
250,000 |
250,000 |
2.25 |
% |
|
| BLFS |
Biolife Solutions Inc |
10% Owner |
– – • |
2023-05-17 |
4 |
B |
$21.30 |
$639,446 |
I/I |
30,027 |
45,027 |
1.5 |
% |
|
| BLFS |
Biolife Solutions Inc |
10% Owner |
– – • |
2023-05-18 |
4 |
B |
$21.76 |
$652,692 |
I/I |
30,000 |
75,027 |
1.5 |
% |
|
| FLDM |
Fluidigm Corp |
Director |
– • • |
2023-05-18 |
4 |
B |
$2.16 |
$323,865 |
I/I |
150,000 |
400,000 |
2.25 |
% |
|
| FLDM |
Fluidigm Corp |
Director |
– • • |
2023-05-19 |
4 |
B |
$2.29 |
$1,835,920 |
I/I |
800,000 |
1,200,000 |
2.25 |
% |
|
| BLFS |
Biolife Solutions Inc |
10% Owner |
– – • |
2023-05-19 |
4 |
B |
$22.55 |
$1,127,430 |
I/I |
50,000 |
125,027 |
1.5 |
% |
|
68 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
